<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37684700</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1478-6362</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>08</Day></PubDate></JournalIssue><Title>Arthritis research &amp; therapy</Title><ISOAbbreviation>Arthritis Res Ther</ISOAbbreviation></Journal><ArticleTitle>Novel CSF biomarkers for diagnosis and integrated analysis of neuropsychiatric systemic lupus erythematosus: based on antibody profiling.</ArticleTitle><Pagination><StartPage>165</StartPage><MedlinePgn>165</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">165</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13075-023-03146-z</ELocationID><Abstract><AbstractText Label="BACKGROUND">Neuropsychiatric systemic lupus erythematosus (NPSLE), with various morbidities and multiple manifestations in the central nervous system, remains a limited standard for diagnosis. Our study was to discover novel biomarkers for improving the diagnostic efficiency for NPSLE.</AbstractText><AbstractText Label="METHODS">We performed a quantitative planar protein antibody microarray to screen 1000 proteins in cerebrospinal fluid from controls, systemic lupus erythematosus (SLE, non-NPSLE) patients, and NPSLE patients. Differentially expressed proteins (DEPs) as candidate biomarkers were developed into a custom multiplexed protein antibody array for further validation in an independent larger cohort. Subsequently, we used least absolute shrinkage and selection operator regression (LASSO) analysis and multivariable logistic regression analysis for optimizing feature selection and constructing a diagnostic model. A receiver operating characteristic curve (ROC) was generated to assess the effectiveness of the models.</AbstractText><AbstractText Label="RESULTS">The expression of 29 proteins in CSF was significantly altered in the comparison of the three groups. We selected 17 proteins as candidate biomarkers in accordance with protein interaction analysis. In the larger cohort, we identified 5 DEPs as biomarkers for NPSLE, including TCN2, CST6, KLK5, L-selectin, and Trappin-2. The diagnostic model included 3 hub proteins (CST6, TCN2, KLK5) and was best at discriminating NPSLE from SLE patients. These CSF biomarkers were also highly associated with disease activity. In addition, there were 6 molecules with remarkable changes in NPSLE CSF and hippocampus, which indicated the consistency of the environment in the brain and the promising molecular targets in the pathogenesis of NPSLE.</AbstractText><AbstractText Label="CONCLUSIONS">The dual-chips screening strategy demonstrated KLK5, L-selectin, Trappin-2, TCN2, and CST6 as CSF biomarkers for diagnosing NPSLE.</AbstractText><CopyrightInformation>&#xa9; 2023. BioMed Central Ltd., part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ni</LastName><ForeName>Jiali</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The State Key Laboratory of Pharmaceutical Biotechnology, Division of Immunology, Medical School, Nanjing University, Nanjing, 210093, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Clinical Nutrition, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shuangan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The State Key Laboratory of Pharmaceutical Biotechnology, Division of Immunology, Medical School, Nanjing University, Nanjing, 210093, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The State Key Laboratory of Pharmaceutical Biotechnology, Division of Immunology, Medical School, Nanjing University, Nanjing, 210093, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Liping</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The State Key Laboratory of Pharmaceutical Biotechnology, Division of Immunology, Medical School, Nanjing University, Nanjing, 210093, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The State Key Laboratory of Pharmaceutical Biotechnology, Division of Immunology, Medical School, Nanjing University, Nanjing, 210093, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The State Key Laboratory of Pharmaceutical Biotechnology, Division of Immunology, Medical School, Nanjing University, Nanjing, 210093, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Yayi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The State Key Laboratory of Pharmaceutical Biotechnology, Division of Immunology, Medical School, Nanjing University, Nanjing, 210093, China. yayihou@nju.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Molecular Medicine, Nanjing, 210093, China. yayihou@nju.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dou</LastName><ForeName>Huan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>The State Key Laboratory of Pharmaceutical Biotechnology, Division of Immunology, Medical School, Nanjing University, Nanjing, 210093, China. douhuan@nju.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Molecular Medicine, Nanjing, 210093, China. douhuan@nju.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China. 13505193169@139.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Arthritis Res Ther</MedlineTA><NlmUniqueID>101154438</NlmUniqueID><ISSNLinking>1478-6354</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>126880-86-2</RegistryNumber><NameOfSubstance UI="D019041">L-Selectin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000906">Antibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020945" MajorTopicYN="Y">Lupus Vasculitis, Central Nervous System</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019041" MajorTopicYN="N">L-Selectin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000906" MajorTopicYN="N">Antibodies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biomarkers</Keyword><Keyword MajorTopicYN="N">Diagnosis</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">NPSLE</Keyword><Keyword MajorTopicYN="N">Protein array</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>9</Day><Hour>11</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>8</Day><Hour>23</Hour><Minute>47</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37684700</ArticleId><ArticleId IdType="pmc">PMC10486090</ArticleId><ArticleId IdType="doi">10.1186/s13075-023-03146-z</ArticleId><ArticleId IdType="pii">10.1186/s13075-023-03146-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schwartz N, Stock AD, Putterman C. Neuropsychiatric lupus: new mechanistic insights and future treatment directions. Nat Rev Rheumatol. 2019 doi: 10.1038/s41584-018-0156-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-018-0156-8</ArticleId><ArticleId IdType="pmc">PMC8023338</ArticleId><ArticleId IdType="pubmed">30659245</ArticleId></ArticleIdList></Reference><Reference><Citation>The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999; 10.1002/1529-0131.</Citation><ArticleIdList><ArticleId IdType="pubmed">10211873</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 doi: 10.1002/art.1780400928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780400928</ArticleId><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanly JG. Diagnosis and management of neuropsychiatric SLE. Nat Rev Rheumatol. 2014 doi: 10.1038/nrrheum.2014.15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2014.15</ArticleId><ArticleId IdType="pubmed">24514913</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan G, Baby B, Zhou Y, Wu T. Emerging molecular markers towards potential diagnostic panels for lupus. Front Immunol. 2022 doi: 10.3389/fimmu.2021.808839.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.808839</ArticleId><ArticleId IdType="pmc">PMC8792845</ArticleId><ArticleId IdType="pubmed">35095896</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolopoulos D, Fanouriakis A, Bertsias G. Treatment of neuropsychiatric systemic lupus erythematosus: clinical challenges and future perspectives. Expert Rev Clin Immunol. 2021 doi: 10.1080/1744666X.2021.1899810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2021.1899810</ArticleId><ArticleId IdType="pubmed">33682602</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos FPST, Nascimento BR, Calderaro DC, Ferreira GA, Correa H. Neuropsychiatric syndromes in childhood-onset systemic lupus erythematosus: a systematic review and meta-analysis. J Clin Rheumatol. 2021 doi: 10.1097/RHU.0000000000001029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RHU.0000000000001029</ArticleId><ArticleId IdType="pubmed">31022053</ArticleId></ArticleIdList></Reference><Reference><Citation>Unterman A, Nolte JE, Boaz M, Abady M, Shoenfeld Y, Zandman-Goddard G. Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. Semin Arthritis Rheum. 2011 doi: 10.1016/j.semarthrit.2010.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2010.08.001</ArticleId><ArticleId IdType="pubmed">20965549</ArticleId></ArticleIdList></Reference><Reference><Citation>Borowoy AM, Pope JE, Silverman E, et al. Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort. Semin Arthritis Rheum. 2012 doi: 10.1016/j.semarthrit.2012.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2012.03.011</ArticleId><ArticleId IdType="pubmed">22595642</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardridge WM. CSF, blood-brain barrier, and brain drug delivery. Expert Opin Drug Deliv. 2016 doi: 10.1517/17425247.2016.1171315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/17425247.2016.1171315</ArticleId><ArticleId IdType="pubmed">27020469</ArticleId></ArticleIdList></Reference><Reference><Citation>Carri&#xf3;n-Barber&#xe0; I, Salman-Monte TC, V&#xed;lchez-Oya F, Monfort J. Neuropsychiatric involvement in systemic lupus erythematosus: a review. Autoimmun Rev. 2021 doi: 10.1016/j.autrev.2021.102780.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102780</ArticleId><ArticleId IdType="pubmed">33609799</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho RC, Thiaghu C, Ong H, et al. A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus. Autoimmun Rev. 2016 doi: 10.1016/j.autrev.2015.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2015.10.003</ArticleId><ArticleId IdType="pubmed">26497108</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Yoav, Hochberg Yosef. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B (Methodological). 1995;57:289&#x2013;300.</Citation></Reference><Reference><Citation>Doncheva NT, Morris JH, Gorodkin J, Jensen LJ. Cytoscape StringApp: network analysis and visualization of proteomics data. J Proteome Res. 2019 doi: 10.1021/acs.jproteome.8b00702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.8b00702</ArticleId><ArticleId IdType="pmc">PMC6800166</ArticleId><ArticleId IdType="pubmed">30450911</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33:1&#x2013;22. doi: 10.18637/jss.v033.i01.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v033.i01</ArticleId><ArticleId IdType="pmc">PMC2929880</ArticleId><ArticleId IdType="pubmed">20808728</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X, Xu T, Ding C, et al. Neuronal NR4A1 deficiency drives complement-coordinated synaptic stripping by microglia in a mouse model of lupus. Signal Transduct Target Ther. 2022 doi: 10.1038/s41392-021-00867-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00867-y</ArticleId><ArticleId IdType="pmc">PMC8854434</ArticleId><ArticleId IdType="pubmed">35177587</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao X, Wang H, Lu L, et al. Hippocampal microglia CD40 mediates NPSLE cognitive dysfunction in mice. J Neuroimmunol. 2021 doi: 10.1016/j.jneuroim.2021.577620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2021.577620</ArticleId><ArticleId IdType="pubmed">34062352</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Zhu X, Shen J, et al. Quantitative iTRAQ-based proteomic analysis of differentially expressed proteins in aging in human and monkey. BMC Genomics. 2019 doi: 10.1186/s12864-019-6089-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12864-019-6089-z</ArticleId><ArticleId IdType="pmc">PMC6788010</ArticleId><ArticleId IdType="pubmed">31601169</ArticleId></ArticleIdList></Reference><Reference><Citation>Corsi MM, Licastro F, Porcellini E, et al. Reduced plasma levels of P-selectin and L-selectin in a pilot study from Alzheimer disease: relationship with neuro-degeneration. Biogerontology. 2011 doi: 10.1007/s10522-011-9335-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10522-011-9335-6</ArticleId><ArticleId IdType="pubmed">21484243</ArticleId></ArticleIdList></Reference><Reference><Citation>Iikuni N, Okamoto H, Yoshio T, et al. Raised monocyte chemotactic protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus. Ann Rheum Dis. 2006 doi: 10.1136/ard.2005.041640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2005.041640</ArticleId><ArticleId IdType="pmc">PMC1798013</ArticleId><ArticleId IdType="pubmed">16410530</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirohata S, Kanai Y, Mitsuo A et al. NPSLE Research Subcommittee. Accuracy of cerebrospinal fluid IL-6 testing for diagnosis of lupus psychosis. A multicenter retrospective study. Clin Rheumatol. 2009; 10.1007/s10067-009-1226-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">19593599</ArticleId></ArticleIdList></Reference><Reference><Citation>Gherasim C, Lofgren M, Banerjee R. Navigating the B (12) road: assimilation, delivery, and disorders of cobalamin. J Biol Chem. 2013 doi: 10.1074/jbc.R113.458810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R113.458810</ArticleId><ArticleId IdType="pmc">PMC3650358</ArticleId><ArticleId IdType="pubmed">23539619</ArticleId></ArticleIdList></Reference><Reference><Citation>Sj&#xf6;din S, Brinkmalm G, &#xd6;hrfelt A, et al. Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease. Alzheimers Res Ther. 2019 doi: 10.1186/s13195-019-0533-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-019-0533-9</ArticleId><ArticleId IdType="pmc">PMC6745076</ArticleId><ArticleId IdType="pubmed">31521194</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia L, Wang Y, Wei W, et al. Vitamin B12 inhibits &#x3b1;-synuclein fibrillogenesis and protects against amyloid-induced cytotoxicity. Food Funct. 2019 doi: 10.1039/c8fo02471e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c8fo02471e</ArticleId><ArticleId IdType="pubmed">31070198</ArticleId></ArticleIdList></Reference><Reference><Citation>Sha HY, Zhao JB, Sha MX, Guo SM. Effects of Vitamin B12 on postoperative cognitive dysfunction induced by isoflurane anesthesia in rats. Eur Rev Med Pharmacol Sci. 2017;21:1959&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">28485779</ArticleId></ArticleIdList></Reference><Reference><Citation>W allin H, Apelqvist J, Andersson F, Ekstr&#xf6;m U, Abrahamson M. Low-level internalization of cystatin E/M affects legumain activity and migration of melanoma cells. J Biol Chem. 2017; 10.1074/jbc.M117.776138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5582836</ArticleId><ArticleId IdType="pubmed">28630039</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Liang Y, Lian C, et al. CST6 protein and peptides inhibit breast cancer bone metastasis by suppressing CTSB activity and osteoclastogenesis. Theranostics. 2021 doi: 10.7150/thno.62187.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.62187</ArticleId><ArticleId IdType="pmc">PMC8581426</ArticleId><ArticleId IdType="pubmed">34815788</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafsson JT, Simard JF, Gunnarsson I, et al. Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study. Arthritis Res Ther. 2012 doi: 10.1186/ar3759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar3759</ArticleId><ArticleId IdType="pmc">PMC4060356</ArticleId><ArticleId IdType="pubmed">22390680</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaidi SH, You XM, Ciura S, Husain M, Rabinovitch M. Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension. Circulation. 2002 doi: 10.1161/hc0402.102866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/hc0402.102866</ArticleId><ArticleId IdType="pubmed">11815437</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado GF, Melo GD, Souza MS, et al. Zymographic patterns of MMP-2 and MMP-9 in the CSF and cerebellum of dogs with subacute distemper leukoencephalitis. Vet Immunol Immunopathol. 2013 doi: 10.1016/j.vetimm.2013.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetimm.2013.04.006</ArticleId><ArticleId IdType="pmc">PMC7127742</ArticleId><ArticleId IdType="pubmed">23639293</ArticleId></ArticleIdList></Reference><Reference><Citation>Trysberg E, Blennow K, Zachrisson O, Tarkowski A. Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement. Arthritis Res Ther. 2004 doi: 10.1186/ar1228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar1228</ArticleId><ArticleId IdType="pmc">PMC1064867</ArticleId><ArticleId IdType="pubmed">15535833</ArticleId></ArticleIdList></Reference><Reference><Citation>Abuduhadeer X, Xu X, Aihesan K, Yilihamu M, Zhao Y, Zhang W. Clinical significance of kallikrein 5 as a novel prognostic biomarker in gastric adenocarcinoma. J Clin Lab Anal. 2021 doi: 10.1002/jcla.23958.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.23958</ArticleId><ArticleId IdType="pmc">PMC8529136</ArticleId><ArticleId IdType="pubmed">34510543</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang JS, Kim N, Kim JY, et al. Kallikrein 5 overexpression is associated with poor prognosis in uterine cervical cancer. J Gynecol Oncol. 2020 doi: 10.3802/jgo.2020.31.e78.</Citation><ArticleIdList><ArticleId IdType="doi">10.3802/jgo.2020.31.e78</ArticleId><ArticleId IdType="pmc">PMC7593226</ArticleId><ArticleId IdType="pubmed">33078588</ArticleId></ArticleIdList></Reference><Reference><Citation>Baraczka K, Pozsonyi T, N&#xe9;k&#xe1;m K, et al. Soluble L-selectin levels in serum and cerebrospinal fluid in patients with multiple sclerosis and systemic lupus erythematosus. Acta Neurol Scand. 2000 doi: 10.1034/j.1600-0404.2000.102002114.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-0404.2000.102002114.x</ArticleId><ArticleId IdType="pubmed">10949528</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaccagni H, Fried J, Cornell J, Padilla P, Brey RL. Soluble adhesion molecule levels, neuropsychiatric lupus and lupus-related damage. Front Biosci. 2004 doi: 10.2741/1273.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/1273</ArticleId><ArticleId IdType="pubmed">14977576</ArticleId></ArticleIdList></Reference><Reference><Citation>Jasiak-Zato&#x144;ska M, Pietrzak A, Wyciszkiewicz A, et al. Different blood-brain-barrier disruption profiles in multiple sclerosis, neuromyelitis optica spectrum disorders, and neuropsychiatric systemic lupus erythematosus. Neurol Neurochir Pol. 2022 doi: 10.5603/PJNNS.a2022.0013.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/PJNNS.a2022.0013</ArticleId><ArticleId IdType="pubmed">35118639</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Strickland MR, Soranno A, Holtzman DM. Apolipoprotein E: structural insights and links to Alzheimer disease pathogenesis. Neuron. 2021 doi: 10.1016/j.neuron.2020.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.10.008</ArticleId><ArticleId IdType="pmc">PMC7931158</ArticleId><ArticleId IdType="pubmed">33176118</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson LA, Olsen RH, Merkens LS, et al. Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner. Neurobiol Dis. 2014 doi: 10.1016/j.nbd.2013.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.12.016</ArticleId><ArticleId IdType="pmc">PMC3936477</ArticleId><ArticleId IdType="pubmed">24412220</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu L, Kong W, Zhou K, et al. Association of lipoproteins and thyroid hormones with cognitive dysfunction in patients with systemic lupus erythematosus. BMC Rheumatol. 2021 doi: 10.1186/s41927-021-00190-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41927-021-00190-7</ArticleId><ArticleId IdType="pmc">PMC8188676</ArticleId><ArticleId IdType="pubmed">34103098</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomita M, Khan RL, Blehm BH, Santoro TJ. The potential pathogenetic link between peripheral immune activation and the central innate immune response in neuropsychiatric systemic lupus erythematosus. Med Hypotheses. 2004 doi: 10.1016/j.mehy.2003.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2003.10.009</ArticleId><ArticleId IdType="pubmed">14975498</ArticleId></ArticleIdList></Reference><Reference><Citation>Saki&#x107; B, Szechtman H, Denburg JA, Gorny G, Kolb B, Whishaw IQ. Progressive atrophy of pyramidal neuron dendrites in autoimmune MRL-lpr mice. J Neuroimmunol. 1998 doi: 10.1016/s0165-5728(98)00085-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0165-5728(98)00085-x</ArticleId><ArticleId IdType="pubmed">9670858</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu L, Wang H, Liu X, et al. Pyruvate kinase isoform M2 impairs cognition in systemic lupus erythematosus by promoting microglial synaptic pruning via the &#x3b2;-catenin signaling pathway. J Neuroinflammation. 2021 doi: 10.1186/s12974-021-02279-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02279-9</ArticleId><ArticleId IdType="pmc">PMC8513209</ArticleId><ArticleId IdType="pubmed">34645459</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Geng L, Xu X, et al. Comparative proteomics analysis of plasma protein in patients with neuropsychiatric systemic lupus erythematosus. Ann Transl Med. 2020 doi: 10.21037/atm.2020.04.58.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm.2020.04.58</ArticleId><ArticleId IdType="pmc">PMC7290550</ArticleId><ArticleId IdType="pubmed">32566606</ArticleId></ArticleIdList></Reference><Reference><Citation>Schutzer SE, Liu T, Natelson BH, et al. Establishing the proteome of normal human cerebrospinal fluid. PLoS One. 2010 doi: 10.1371/journal.pone.0010980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0010980</ArticleId><ArticleId IdType="pmc">PMC2881861</ArticleId><ArticleId IdType="pubmed">20552007</ArticleId></ArticleIdList></Reference><Reference><Citation>Aman-Mohammady A, Saadat P, Qujeq D, Hajian-Tilaki K, Saleki K. Determination of plasma transcobalamin-II and zinc levels in newly-diagnosed and long-standing grand mal epileptic patients. Caspian J Intern Med. 2023 doi: 10.22088/cjim.14.2.199.</Citation><ArticleIdList><ArticleId IdType="doi">10.22088/cjim.14.2.199</ArticleId><ArticleId IdType="pmc">PMC10201111</ArticleId><ArticleId IdType="pubmed">37223292</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco P, Gu&#xe9;ant-Rodriguez RM, Anello G, et al. Association of homocysteine (but not of MTHFR 677 C&gt;T, MTR 2756 A&gt;G, MTRR 66 A&gt;G and TCN2 776 C&gt;G) with ischaemic cerebrovascular disease in Sicily. Thromb Haemost. 2006;96(2):154&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">16894458</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei YS, Lan Y, Meng LQ, Nong LG. The association of L-selectin polymorphisms with L-selectin serum levels and risk of ischemic stroke. J Thromb Thrombolysis. 2011 doi: 10.1007/s11239-011-0587-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-011-0587-4</ArticleId><ArticleId IdType="pubmed">21465128</ArticleId></ArticleIdList></Reference><Reference><Citation>Faulcon LM, Fu Z, Dulloor P, et al. Thrombospondin-1 and L-selectin are associated with silent cerebral infarct in children with sickle cell anaemia. Br J Haematol. 2013 doi: 10.1111/bjh.12374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.12374</ArticleId><ArticleId IdType="pmc">PMC4391368</ArticleId><ArticleId IdType="pubmed">23672305</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>